PMC7166280_01
Clinical course of the case. Mean blood glucose was calculated as the average of four measurements (before each meal and sleep (approximately 2 h after dinner)). The upper panel shows an outline of treatment, including the daily insulin dose (unit/day), IGF-1 (mg/day), PSL (mg/day), and oral hypoglycemic agents and changes in the anti-insulin receptor antibody. The middle panel shows the transition of FBG, IRI, and CPR, and the lower panel shows the transition of detailed FBG, mean blood glucose, and body weight. BW: body weight; CPR: C-peptide; FBG: fasting blood glucose; IGF-1: insulin-like growth factor-1; IRI: immunoreactive insulin; PSL: prednisolone; Ab: antibody. The blood glucose level above the upper limit of measurement (600 mg/dL, 33.3 mmol/L) of the self-monitoring blood glucose meter was calculated as 600 mg/dL (33.3 mmol/L).
JDR2020-4359787.002.jpg
PMC7166280_01_JDR2020-4359787.002.jpg
fig2
 Figure 2 summarizes the clinical course.